Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Farmakon AS
AS
Active
Org 930476676
Frøyas Vei 27A, 1412
Sofiemyr
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2022 · 3 years old
4 employees
Monitor
Share
Norway
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Farmakon AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
4M
3M
2M
1M
0M
2022: 0M
0M
2022
2023: 2M
2M
2023
2024: 3M (+50% vs 2023)
3M
+50%
2024
2025: 2M (-33% vs 2024)
2M
-33%
2025
EBITDA
NOK millions
1M
1M
1M
0M
0M
2022: 0M
0M
2022
2023: 1M
1M
2023
2024: 1M (0% vs 2023)
1M
0%
2024
2025: 0M (-100% vs 2024)
0M
-100%
2025
Income statement
NOK thousands
Item
2025
2024
2023
2022
Revenue
1 844
3 151
2 177
0
Staff expenses
−1 001
−1 864
−1 022
−0
EBITDA
311
952
909
0
Depreciation & amort.
−24
−12
−0
−0
EBIT
287
939
909
0
Net financials
−1
−11
−4
0
Profit before tax
286
929
905
0
Tax
67
−1
203
−0
Net profit
220
930
703
0
Balance sheet
NOK thousands
Item
2025
2024
2023
2022
Total assets
1 050
1 897
1 386
24
Equity
571
552
222
24
Long-term debt
27
27
27
0
Short-term debt
452
1 318
1 138
0
Total debt
479
1 345
1 165
0
Financial ratios
5-year trend
EBITDA margin
16,9 %
This company
15,8 %
Market median
This company
Market median
7% above market
2022
2025
Equity ratio
54,4 %
This company
38,2 %
Market median
This company
Market median
42% above market
2022
2025
Return on equity
38,4 %
This company
18,4 %
Market median
This company
Market median
109% above market
2022
2025
Net profit margin
11,9 %
This company
8,1 %
Market median
This company
Market median
47% above market
2022
2025
Asset turnover
1,76×
This company
1,12×
Market median
This company
Market median
57% above market
2022
2025
Debt / equity
0,84×
This company
0,62×
Market median
This company
Market median
35% above market
2022
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
More on Farmakon AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
